Showing results (4481-4490 of 6,438) with videos related to
Sort By:
Pageof 644
Clinical Biochemistry|November 14, 2020
Sfrp5/Wnt5a and leptin/adiponectin levels in the serum and the periarterial adipose tissue of patients with peripheral arterial occlusive diseaseBiyu Wang, Yu Pan, Guang Yang, et al.Clinical Biochemistry|November 14, 2020
Evaluation of sporadic bovine alkaline phosphatase interference in the Beckman Access unconjugated estriol (uE3) assay affecting maternal serum screening resultsJoshua A Bornhorst, Paola A Ramos, Elizabeth R Sutterer, et al.Clinical Biochemistry|August 1, 1987
Diagnostic aspects of alkaline phosphatase and its isoenzymesD W MossClinical Biochemistry|February 26, 2020
Label-free peptide quantification coupled with in silico mapping of proteases for identification of potential serum biomarkers in gastric adenocarcinoma patientsTalita Mendes de Oliveira, José Thalles Jocelino Gomes de Lacerda, Giuseppe Gianini Figueiredo Leite, et al.Clinical Biochemistry|July 27, 2015
A call for a value based approach to laboratory medicine fundingA St John, G Edwards, S Fisher, et al.Clinical Biochemistry|December 23, 2014
Sweating the small stuff: adequacy and accuracy in sweat chloride determinationMari L DeMarco, Dennis J Dietzen, Sarah M BrownClinical Biochemistry|March 11, 2018
A critical evaluation of the Beckman Coulter Access hsTnI: Analytical performance, reference interval and concordanceCarel J Pretorius, Jillian R Tate, Urs Wilgen, et al.Clinical Biochemistry|December 12, 2018
Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancerSebastian Stasik, Karsten Salomo, Ulrike Heberling, et al.Clinical Biochemistry|August 15, 2017
The 99th percentile and imprecision of point-of-care cardiac troponin I in comparison to central laboratory tests in a large reference populationAnne Greiser, Theresa Winter, Hala Mahfoud, et al.Clinical Biochemistry|August 22, 2017
Serum microRNA profiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injuryYu Yamaura, Naoyuki Tatsumi, Shingo Takagi, et al.Pageof 644